Morabito Christopher's Form 4 filing
Astria Therapeutics, Inc. (ATXS) · filed Jan 30, 2024
- Accession no.
- 0001104659-24-008327
- Filed
- Jan 30, 2024
- Trade date
- Jan 26-29, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $111.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morabito ChristopherCIK 0001859284 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | Common Stock | MOption exerciseAcquired | +800 | $3.87 | +$3,096 | 800 | Direct | |
| Jan 26, 2024 | Common Stock | SSaleDisposed | −800 | $11.02 | −$8,816 | 0 | Direct | |
| Jan 29, 2024 | Common Stock | MOption exerciseAcquired | +9,200 | $3.87 | +$35,604 | 9,200 | Direct | |
| Jan 29, 2024 | Common Stock | SSaleDisposed | −9,200 | $11.15 | −$102,580 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | Common Stock | MOption exerciseDisposed | −800 | $0.00 | $0 | 99,200 | Direct | |
| Jan 29, 2024 | Common Stock | MOption exerciseDisposed | −9,200 | $0.00 | $0 | 90,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.